In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Verve Therapeutics Inc’s stock clocked out at $5.93, up 3.49% from its previous closing price of $5.73. In other words, the price has increased by $3.49 from its previous closing price. On the day, 1.16 million shares were traded. VERV stock price reached its highest trading level at $5.955 during the session, while it also had its lowest trading level at $5.65.
Ratios:
To gain a deeper understanding of VERV’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.64 and its Current Ratio is at 14.64. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 08, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $29.
On February 01, 2023, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $21.Cantor Fitzgerald initiated its Neutral rating on February 01, 2023, with a $21 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 14 ’24 when Ashe Andrew D. bought 76,000 shares for $6.26 per share. The transaction valued at 475,760 led to the insider holds 342,509 shares of the business.
Nickerson Joan sold 1,514 shares of VERV for $12,475 on Apr 02 ’24. The Chief Administrative Officer now owns 8,659 shares after completing the transaction at $8.24 per share. On Nov 29 ’23, another insider, Dorval Allison, who serves as the Chief Financial Officer of the company, sold 554 shares for $11.45 each. As a result, the insider received 6,343 and left with 4,060 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERV now has a Market Capitalization of 501823232 and an Enterprise Value of -1648543. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.15 while its Price-to-Book (P/B) ratio in mrq is 0.92. Its current Enterprise Value per Revenue stands at -0.08 whereas that against EBITDA is 0.008.
Stock Price History:
Over the past 52 weeks, VERV has reached a high of $20.12, while it has fallen to a 52-week low of $4.30. The 50-Day Moving Average of the stock is 9.87%, while the 200-Day Moving Average is calculated to be -23.27%.
Shares Statistics:
It appears that VERV traded 1.35M shares on average per day over the past three months and 1082230 shares per day over the past ten days. A total of 81.97M shares are outstanding, with a floating share count of 62.47M. Insiders hold about 26.18% of the company’s shares, while institutions hold 66.64% stake in the company. Shares short for VERV as of 1728950400 were 17439717 with a Short Ratio of 12.96, compared to 1726185600 on 15868915. Therefore, it implies a Short% of Shares Outstanding of 17439717 and a Short% of Float of 24.6.
